Saltar al contenido
MilliporeSigma

Adverse effect of valproic acid on an in vitro gastrulation model entails activation of retinoic acid signaling.

Reproductive toxicology (Elmsford, N.Y.) (2016-10-30)
Aileen S W Li, Yusuke Marikawa
RESUMEN

Valproic acid (VPA), an antiepileptic drug, is a teratogen that causes neural tube and axial skeletal defects, although the mechanisms are not fully understood. We previously established a gastrulation model using mouse P19C5 stem cell embryoid bodies (EBs), which exhibits axial patterning and elongation morphogenesis in vitro. Here, we investigated the effects of VPA on the EB axial morphogenesis to gain insights into its teratogenic mechanisms. Axial elongation and patterning of EBs were inhibited by VPA at therapeutic concentrations. VPA elevated expression levels of various developmental regulators, including Cdx1 and Hoxa1, known transcriptional targets of retinoic acid (RA) signaling. Co-treatment of EBs with VPA and BMS493, an RA receptor antagonist, partially rescued axial elongation as well as gene expression profiles. These results suggest that VPA requires active RA signaling to interfere with EB morphogenesis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
BIO, ≥98% (HPLC)
Sigma-Aldrich
Valpromide, ≥97% (NMR)